ArticleScientific reports2026
Polydopamine-doped PEDOT interfaces improve cell-electrode interactions and neural signal transmission.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here, we report an innovative conductive polymer composite, polydopamine (PDA)-doped poly(3,4-ethylenedioxythiophene) (PEDOT-PDA), deposited onto titanium nitride (TiN) electrodes. TiN films (~ 150 nm thick) were prepared via physical vapor deposition, followed by rapid galvanostatic electrochemical co-polymerization to form pure PEDOT and PEDOT-PDA layers. Field-emission scanning electron microscopy revealed that PEDOT-PDA films exhibit a compact, tightly packed architecture, enhancing structural cohesion, mechanical stability, and charge transport efficiency. Atomic force microscopy demonstrated increased surface roughness of the PEDOT-based coatings compared to the bare TiN substrate, promoting better cell interfacing. Notably, PDA incorporation rendered the PEDOT-PDA surface superhydrophilic, with a contact angle of 7°, representing a substantial improvement over the 65° measured for pure PEDOT films. Electrochemical analyses showed that PEDOT-PDA interfaces achieved a remarkably low impedance of 0.27 Ω, over 94% lower than that of commercial gold electrodes (4.7 Ω), facilitating efficient ion-electron mixed charge transfer via electrochemical (de)doping mechanisms. All fabricated samples exhibited high biocompatibility (> 85% cell viability), with PEDOT-PDA films particularly promoting enhanced cell adhesion and spreading, as evidenced by extensive filopodia penetration into the interface layer. Computational simulations further revealed that PDA doping improved the binding energy of PEDOT-based films to cellular membranes by up to 685%, increased lateral molecular diffusion at the interface by nearly 1000%, and boosted the average number of molecular contacts (~ 3010 at 310 K over 5 ns) by 16–47%. Together, experimental and computational results demonstrate that PEDOT-PDA composites significantly enhance both biological and electrochemical interactions at the cell-electrode interface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.